PE106299A1 - DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOL - Google Patents
DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOLInfo
- Publication number
- PE106299A1 PE106299A1 PE1998000717A PE00071798A PE106299A1 PE 106299 A1 PE106299 A1 PE 106299A1 PE 1998000717 A PE1998000717 A PE 1998000717A PE 00071798 A PE00071798 A PE 00071798A PE 106299 A1 PE106299 A1 PE 106299A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- disorders
- trifluoromethyl
- chlorine
- fluorine
- Prior art date
Links
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 3
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000000460 chlorine Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 239000011737 fluorine Substances 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 101100495911 Arabidopsis thaliana CHR10 gene Proteins 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 102100020802 D(1A) dopamine receptor Human genes 0.000 abstract 1
- 229940099567 Dopamine D4 receptor agonist Drugs 0.000 abstract 1
- 101000931925 Homo sapiens D(1A) dopamine receptor Proteins 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE a ES 0-1; CUANDO a ES CERO,"X" PUEDE FORMAR UN ENLACE OPCIONAL CON EL CARBONO ADYACENTE A V; V ES CHR10, R10 ES H o ALQUILO C1-C6; T ES N o CH; X ES N o CR11; R11 ES H, ALQUILO C1-C6, ALCOXI C1-C6, OH, CIANO; "Y" Y Z SON N o CR12; R12 ES H, CLORO, FLUORO, TRIFLUOROMETILO, ENTRE OTROS; R1 ES H, FLUORO, CLORO, BROMO, TRIFLUOROMETILO, ENTRE OTROS; R2, R6, R7, R8, R9 SON H, FLUORO, CLORO, BROMO, ENTRE OTROS; R3 Y R4 SON H o ALQUILO C1-C6; R5 ES H, ALCOXI C1-C6, TRIFLUOROMETILO, ENTRE OTROS; CUANDO a ES 1; R1 Y R1O FORMAN JUNTOS UN COMPUESTO DE FORMULA II; b ES 0-1; A Y B SON CH, CH2, O, S, NH o N. CON LA CONDICION QUE CUANDO "X" ES N, EL DOBLE ENLACE ENTRE X Y V NO EXISTE, ENTRE OTRAS CONDICIONES. UN COMPUESTO PREFERIDO ES 2-[4-(3-TRIFLUOROMETIL-FENIL)-PIPERAZIN-1-ILMETIL]-1H-INDOL, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS UNO O MAS AGONISTAS DEL RECEPTOR D1, D2, D3, D5 DE DOPAMINA. EL COMPUESTO I ES UN AGONISTA DEL RECEPTOR D4 DE DOPAMINA POR LO QUE PUEDE SER UTIL PARA TRATAR TRASTORNOS DEL SISTEMA DE LA DOPAMINA COMO TRASTORNOS PSICOTICOS, TRASTORNOS DEL MOVIMIENTO, TRASTORNOS GASTROINTESTINALES, ABUSO DE SUSTANCIAS QUIMICAS, TRASTORNOS VASCULARES Y CARDIOVASCULARES, TRASTORNOS OCULARES Y TRASTORNOS DEL SUENOREFERS TO A COMPOUND OF FORMULA I WHERE IS 0-1; WHEN IT IS ZERO, "X" MAY FORM AN OPTIONAL LINK WITH THE CARBON ADJACENT TO V; V IS CHR10, R10 IS H or C1-C6-ALKYL; T IS N or CH; X IS N ° CR11; R11 IS H, C1-C6 ALKYL, C1-C6 ALCOXY, OH, CIANO; "Y" Y Z ARE No. CR12; R12 IS H, CHLORINE, FLUORINE, TRIFLUOROMETHYL, AMONG OTHERS; R1 IS H, FLUORINE, CHLORINE, JOKE, TRIFLUOROMETHYL, AMONG OTHERS; R2, R6, R7, R8, R9 ARE H, FLUORINE, CHLORINE, JOKE, AMONG OTHERS; R3 AND R4 ARE H or C1-C6 ALKYL; R5 IS H, C1-C6 ALCOXY, TRIFLUOROMETHYL, AMONG OTHERS; WHEN IS 1; R1 AND R1O TOGETHER TOGETHER A COMPOUND OF FORMULA II; b ES 0-1; A AND B ARE CH, CH2, O, S, NH or N. WITH THE CONDITION THAT WHEN "X" IS N, THE DOUBLE LINK BETWEEN X AND V DOES NOT EXIST, AMONG OTHER CONDITIONS. A PREFERRED COMPOUND IS 2- [4- (3-TRIFLUOROMETIL-FENIL) -PIPERAZIN-1-ILMETIL] -1H-INDOL, AMONG OTHERS. IT ALSO REFERS TO A COMPOSITION FURTHER COMPRISING ONE OR MORE DOPAMINE RECEPTOR D1, D2, D3, D5 AGONISTS. COMPOUND I IS A DOPAMINE D4 RECEPTOR AGONIST SO IT MAY BE USEFUL FOR TREATING DOPAMINE SYSTEM DISORDERS SUCH AS PSYCHOTIC DISORDERS, MOVEMENT DISORDERS, GASTRAST DISORDERS, TRASTS, CHASTERS AND CHASTERS. OF THE DREAM
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5576497P | 1997-08-15 | 1997-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE106299A1 true PE106299A1 (en) | 1999-11-02 |
Family
ID=22000003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000717A PE106299A1 (en) | 1997-08-15 | 1998-08-10 | DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOL |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1003739A2 (en) |
| JP (1) | JP2002536291A (en) |
| KR (1) | KR20010022507A (en) |
| CN (1) | CN1265660A (en) |
| AP (1) | AP9801321A0 (en) |
| AR (1) | AR017019A1 (en) |
| AU (1) | AU8457298A (en) |
| BG (1) | BG104069A (en) |
| BR (1) | BR9811557A (en) |
| CA (1) | CA2297486C (en) |
| CO (1) | CO4960656A1 (en) |
| DZ (1) | DZ2583A1 (en) |
| EA (1) | EA200000023A1 (en) |
| HR (1) | HRP980441A2 (en) |
| HU (1) | HUP0003425A3 (en) |
| ID (1) | ID23803A (en) |
| IL (1) | IL133960A0 (en) |
| IS (1) | IS5336A (en) |
| MA (1) | MA24632A1 (en) |
| NO (1) | NO20000722D0 (en) |
| OA (1) | OA11286A (en) |
| PA (1) | PA8457001A1 (en) |
| PE (1) | PE106299A1 (en) |
| PL (1) | PL338947A1 (en) |
| SK (1) | SK1352000A3 (en) |
| TN (1) | TNSN98151A1 (en) |
| TR (1) | TR200000414T2 (en) |
| UY (1) | UY25144A1 (en) |
| WO (1) | WO1999009025A2 (en) |
| ZA (1) | ZA987304B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9813279B1 (en) * | 1997-10-27 | 2010-11-16 | homopiperazine derivative, pharmaceutical composition, and use of the homopiperazine derivative. | |
| EP0953567A3 (en) * | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
| UA73756C2 (en) | 1999-12-30 | 2005-09-15 | Lundbeck & Co As H | HALOGEN-SUBSTITUTED 4-PHENYL-1-PIPERAZIN, PIPERIDIN AND TETRAHYDROPIRIDINE û DERIVATIVES A PHARMACEUTICAL COMPOSITION BASED THEREON, THEIR APPLICATION FOR PRODUCING MEDICAMENT, AND A METHOD FOR THE TREATMENT OF PSYCHOSIS |
| GB0017952D0 (en) * | 2000-07-22 | 2000-09-13 | Univ Manchester | Treatment of dyskinesia |
| EP1177792A3 (en) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| MXPA03008143A (en) * | 2001-03-09 | 2005-08-16 | Johnson & Johnson | Heterocyclic compounds. |
| AU2003265886A1 (en) | 2002-09-06 | 2004-03-29 | Janssen Pharmaceutica N.V. | (1H-Benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine H4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
| WO2005095338A1 (en) | 2004-03-30 | 2005-10-13 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| US7572805B2 (en) | 2004-07-14 | 2009-08-11 | Bristol-Myers Squibb Company | Pyrrolo(oxo)isoquinolines as 5HT ligands |
| US7618980B2 (en) | 2004-07-14 | 2009-11-17 | Bristol-Myers Squibb Company | Pyrrolo(oxo)quinolines as 5HT ligands |
| JO2769B1 (en) * | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Fast Dissociting Dopamine 2 Receptor Antagonists |
| JO2642B1 (en) * | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Fast Dissociating Dopamine 2 Receptor Antagonists |
| JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Fast -Dissociating Dopamine 2 Receptor Antagonists |
| CA2682671C (en) | 2007-04-23 | 2015-11-17 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| MX2009011415A (en) | 2007-04-23 | 2009-11-05 | Janssen Pharmaceutica Nv | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists. |
| EP2310374B1 (en) | 2008-07-03 | 2012-10-31 | Janssen Pharmaceutica N.V. | Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| EA019048B1 (en) | 2008-07-31 | 2013-12-30 | Янссен Фармацевтика Нв | Piperazin-1-yl-trifluoromethyl-substituted pyridines as fast dissociating dopamine 2 receptor antagonists |
| CN109843872B (en) * | 2017-09-20 | 2022-08-30 | 杭州英创医药科技有限公司 | Polycyclic compounds as IDO inhibitors and/or IDO-HDAC dual inhibitors |
| EP4139291A4 (en) * | 2020-04-22 | 2024-05-29 | Anima Biotech Inc. | Collagen 1 translation inhibitors and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB944443A (en) * | 1959-09-25 | 1900-01-01 | ||
| ES2097341T3 (en) * | 1991-07-03 | 1997-04-01 | Upjohn Co | SUBSTITUTED INDOLES AS DRUGS FOR THE TREATMENT OF AIDS. |
| JPH05255089A (en) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | Antiviral agent |
| CA2146018A1 (en) * | 1992-10-23 | 1994-05-11 | Paul David Leeson | Dopamine receptor subtype ligands |
| US5576336A (en) * | 1993-03-18 | 1996-11-19 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine D4 antagonists |
| GB9305644D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
| AU6435594A (en) * | 1993-04-15 | 1994-11-08 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
| DE4414113A1 (en) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-indolylpiperidines |
| TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
| ZA968661B (en) * | 1995-11-17 | 1998-04-14 | Upjohn Co | Oxazolidinone antibacterial agent with tricyclic substituents. |
| TW504510B (en) * | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
-
1998
- 1998-08-05 AU AU84572/98A patent/AU8457298A/en not_active Abandoned
- 1998-08-05 PL PL98338947A patent/PL338947A1/en unknown
- 1998-08-05 SK SK135-2000A patent/SK1352000A3/en unknown
- 1998-08-05 EA EA200000023A patent/EA200000023A1/en unknown
- 1998-08-05 AP APAP/P/1998/001321A patent/AP9801321A0/en unknown
- 1998-08-05 CA CA002297486A patent/CA2297486C/en not_active Expired - Fee Related
- 1998-08-05 BR BR9811557-0A patent/BR9811557A/en not_active IP Right Cessation
- 1998-08-05 KR KR1020007001093A patent/KR20010022507A/en not_active Ceased
- 1998-08-05 IL IL13396098A patent/IL133960A0/en unknown
- 1998-08-05 EP EP98935229A patent/EP1003739A2/en not_active Withdrawn
- 1998-08-05 CN CN98807831A patent/CN1265660A/en active Pending
- 1998-08-05 JP JP2000509706A patent/JP2002536291A/en active Pending
- 1998-08-05 WO PCT/IB1998/001198 patent/WO1999009025A2/en not_active Ceased
- 1998-08-05 HU HU0003425A patent/HUP0003425A3/en unknown
- 1998-08-05 TR TR2000/00414T patent/TR200000414T2/en unknown
- 1998-08-05 ID IDW20000197A patent/ID23803A/en unknown
- 1998-08-10 PE PE1998000717A patent/PE106299A1/en not_active Application Discontinuation
- 1998-08-10 PA PA19988457001A patent/PA8457001A1/en unknown
- 1998-08-12 DZ DZ980193A patent/DZ2583A1/en active
- 1998-08-12 MA MA25210A patent/MA24632A1/en unknown
- 1998-08-12 TN TNTNSN98151A patent/TNSN98151A1/en unknown
- 1998-08-13 AR ARP980104021A patent/AR017019A1/en unknown
- 1998-08-14 ZA ZA9807304A patent/ZA987304B/en unknown
- 1998-08-14 CO CO98046788A patent/CO4960656A1/en unknown
- 1998-08-14 HR HR60/055,764A patent/HRP980441A2/en not_active Application Discontinuation
- 1998-08-17 UY UY25144A patent/UY25144A1/en not_active Application Discontinuation
-
2000
- 2000-01-10 BG BG104069A patent/BG104069A/en unknown
- 2000-01-11 IS IS5336A patent/IS5336A/en unknown
- 2000-02-08 OA OA1200000030A patent/OA11286A/en unknown
- 2000-02-14 NO NO20000722A patent/NO20000722D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA987304B (en) | 2000-02-14 |
| JP2002536291A (en) | 2002-10-29 |
| HUP0003425A2 (en) | 2001-10-28 |
| CN1265660A (en) | 2000-09-06 |
| BR9811557A (en) | 2000-08-22 |
| AR017019A1 (en) | 2001-08-22 |
| CA2297486C (en) | 2005-05-03 |
| AP9801321A0 (en) | 2000-02-14 |
| MA24632A1 (en) | 1999-04-01 |
| NO20000722L (en) | 2000-02-14 |
| WO1999009025A2 (en) | 1999-02-25 |
| IL133960A0 (en) | 2001-04-30 |
| IS5336A (en) | 2000-01-11 |
| AU8457298A (en) | 1999-03-08 |
| UY25144A1 (en) | 2000-12-29 |
| PA8457001A1 (en) | 2000-09-29 |
| EP1003739A2 (en) | 2000-05-31 |
| OA11286A (en) | 2003-10-22 |
| KR20010022507A (en) | 2001-03-15 |
| SK1352000A3 (en) | 2000-08-14 |
| CO4960656A1 (en) | 2000-09-25 |
| NO20000722D0 (en) | 2000-02-14 |
| ID23803A (en) | 2000-05-11 |
| EA200000023A1 (en) | 2000-08-28 |
| HRP980441A2 (en) | 1999-04-30 |
| WO1999009025A3 (en) | 1999-04-15 |
| PL338947A1 (en) | 2000-12-04 |
| BG104069A (en) | 2001-05-31 |
| DZ2583A1 (en) | 2003-02-22 |
| HUP0003425A3 (en) | 2002-02-28 |
| TR200000414T2 (en) | 2000-08-21 |
| TNSN98151A1 (en) | 2005-03-15 |
| CA2297486A1 (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE106299A1 (en) | DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOL | |
| PE20010600A1 (en) | DERIVATIVES OF BENZHIMIDAZOLONES HAVING AFFINITY FOR MIXED RECEPTORS OF SEROTONIN AND DOPAMINE | |
| PE2799A1 (en) | LACTAMS AND HETERO-CYCLIC IMIDES OF ARALQUILO AND ARALQUILIDENO | |
| PE20020753A1 (en) | HETEROAROMATICS FUSED AS GLUCOKINASE ACTIVATORS | |
| PE16299A1 (en) | 2-IMIDAZOLINYLAMINOINDOL COMPOUNDS USEFUL AS ALPHA-2 ADRENORECEPTOR AGONISTS | |
| PE20010118A1 (en) | IMIDAZOLE COMPOUNDS SUBSTITUTED AS NEUROPEPTIDE ANTAGONISTS AND | |
| PE20040720A1 (en) | BENZODIOXOL DERIVATIVES | |
| PE20000947A1 (en) | HPPARþ AND hPPARO ACTIVATORS | |
| PE20030610A1 (en) | DERIVATIVES OF 3-AZABICYCLO [3.1.0] HEXANE WITH AFFINITY TO OPIOID RECEPTORS | |
| PE20020637A1 (en) | 5-OXO-PYRROLIDINE DERIVATIVES AS PROSTAGLANDIN AGONISTS | |
| PE68799A1 (en) | TETRAHYDROISOKINOLINE DERIVATIVES AS DOPAMINE D3 RECEPTOR MODULATORS | |
| MX9305277A (en) | 5- (2-4 (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -ETHYL-6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-1-CHLORHYDRATE MONOHYDRATE. | |
| PE20040672A1 (en) | DERIVATIVES OF PHENYL OR HETEROARYL AMINO ALKANE | |
| PE69398A1 (en) | BENZOXAZINONE DOPAMINE D4 RECEPTOR ANTAGONISTS | |
| PE20061328A1 (en) | DERIVATIVES OF OXADIAZOLE OR TIADIAZOLE AS INHIBITORS OF THE BIOSYNTHESIS OF LEUCOTRIENES | |
| CO4930274A1 (en) | TIAZOL BENZENE SULPHONAMIDES AS B3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | |
| PE20030707A1 (en) | MUSCARINE AGONISTS | |
| AR018370A1 (en) | PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE IT, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| PE20020905A1 (en) | DERIVATIVES OF ALCOXICARBONYLAMINOTETRAZOLIL PHENYL OR ALCOXYCARBONYLAMINE BENZOIC ACID AS IP ANTAGONISTS | |
| PE20080540A1 (en) | 4-PHENYL-2-PYRIDINYL-METHYL COMPOUNDS SUBSTITUTED AS MODULATORS OF THE SODIUM CHANNELS WITH VOLTAGE OPENING | |
| PE20110208A1 (en) | 1,6-DIHYDRO-2H-3-OXA-6-AZA-AS-INDACENE COMPOUNDS | |
| PE20001598A1 (en) | DERIVATIVES OF N- [2- (4-AMINOPHENIL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METANAMINA | |
| PE20050862A1 (en) | HETEROCYCLIC INNANE DERIVATIVES SUBSTITUTE AS ANTAGONISTS OF DOPAMINE D2 AND SEROTONIN 2A RECEPTORS | |
| PE20060734A1 (en) | DERIVATIVE OF PIRROL SUBSTITUTED AS ANTAGONISTS OF THE ANDROGEN RECEPTOR | |
| TR200101808T2 (en) | 3-tetrahydropyridine-4-yl indoles for the treatment of psychotic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |